Cimetidine
- 1 August 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 138 (8) , 1257-1260
- https://doi.org/10.1001/archinte.1978.03630330057016
Abstract
Cimetidine is an H2-receptor antagonist that is capable of marked suppression of gastric acid and pepsin secretion. Patients with active duodenal ulcer disease treated with cimetidine show improved rates of healing and symptom relief compared with placebo-treated controls. Peptic ulcer and diarrhea of Zollinger-Ellison syndrome and other acid hypersecretory states respond to cimetidine treatment, as may stress ulcers and steatorrhea of patients with pancreatic insufficiency who have a suboptimal response to oral pancreatin. Effectiveness with gastric ulcer has been less convincing than with duodenal ulcer. In duodenal ulcer disease, cimetidine need not replace less expensive antacid therapy in most cases and is unlikely to replace definitive surgery for suitable candidates. (Arch Intern Med 138:1257-1260, 1978)This publication has 4 references indexed in Scilit:
- Report on the united states experience with cimetidine in zollinger-ellison syndrome and other hypersecretory statesGastroenterology, 1978
- Reflections on Histamine, Gastric Secretion and the H2ReceptorNew England Journal of Medicine, 1977
- Cimetidine Suppression of Nocturnal Gastric Secretion in Active Duodenal UlcerNew England Journal of Medicine, 1976
- Classification and biological distribution of histamine receptor sub-typesInflammation Research, 1975